Diaper Cream, Non-ZnO

Petrolatum-based and plant-based diaper preventatives without zinc oxide (Aquaphor Original, plain petrolatum, calendula/plant-based formulations). Clean baseline of the Row 7 / Row 8 clean-contaminated pair: non-ZnO formulations do not carry the sphalerite-derived Pb/Cd platform.

This page is a Step 0 lock scaffold for Cat 2 Row 7. Literature evidence will be populated as routed source pages accumulate per the synthesis workflow in CLAUDE.md Part 9. The Step 0 lock document at Category2_Clean_vs_Contaminated_Splits.md is the canonical reference for the row’s clean-vs-contaminated framing and platform attribution.

Who this page is for

Brand legal teams evaluating HMTc Cat 2 certification for the Diaper Cream, Non-ZnO row need to know what the cited literature reports per panel metal, what the applicable regulatory caps are, and how this row relates to its clean-contaminated pair (when applicable). Retailer compliance teams stocking the children’s personal care aisle need the row-level assortment-eligibility view. HMT&C certification thresholds for products in this row are developed under the certification program at heavymetaltested.com, not on this page.

Methodology

This page reports what the cited sources say about heavy-metal concentrations in the Diaper Cream, Non-ZnO row. Speciation is non-substitutable per CLAUDE.md Part 14 (iAs vs tAs, MeHg vs tHg, Cr-VI vs total Cr). Basis is preserved (finished-product as sold). Non-detect handling follows each source’s convention. Pooling avoided across LOD/LOQ, period, geography, and analytical-basis differences. HMT&C certification thresholds for products in this row are developed under the certification program at heavymetaltested.com, not on this page; this public page reports literature evidence only.

Cat 2 dose-pathway methodology supplement (per OPERATING.md Part 7 initiative 3.1) is documented at Cat 2 (Children Personal Care) non-ingestion exposure pathways. That supplement governs how dermal, inhalation, accidental-ingestion, and trans-placental exposure factors apply to this row.

Pair relationship

This is the clean-baseline row of a Cat 2 clean-contaminated pair. The contaminated counterpart is Row 8 (Diaper Cream, ZnO-Based). The Step 0 lock documents the categorical metal-load difference attributable to the contaminated row’s platform ingredient(s); the clean baseline row certifies against limits set to genuinely clean-achievable levels independent of the platform.

Literature Evidence Summary

Literature Evidence Summary

The table below summarizes what the peer-reviewed and government literature cited on this page reports for heavy-metal concentrations in Diaper Cream, Non-ZnO. Values are pulled directly from cited sources without re-aggregation; pooling, percentile selection, and threshold math sit in the staff Standards Workbench rather than this public page.

Methodology rules for speciation, basis preservation, non-detect handling, and source pooling are stated in the Methodology section above and apply to every row below.

Source Evidence Inventory

Hand-curated section. Populated by the synthesis pass as Cat 2 sources are ingested and route to this row. Initial scaffold state: zero contributing sources.

Broad Product Context: Author-Scope Index

Pending: regenerated by tools/evidence/apply-product-broad-context.mjs once broad-scope Cat 2 sources route to this page.

Federal/Regulatory Limits vs Field Findings

Pending. Cat 2 regulatory landscape is fragmented: cosmetics under FDA FD&C Act adulteration provisions (no binding finished-product heavy-metal limits); sunscreens under FDA OTC drug monograph; toothpaste under FDA cosmetic + OTC drug regulation; state-level cosmetic heavy-metal laws (Washington TFCA 2025, New York TCCP). EU 1223/2009 Annex II/III addresses cosmetic ingredient restrictions but not finished-product action levels. Awaiting agency-page ingest.

Levers to reduce contamination

The Cat 2 Step 0 lock framework distinguishes clean-formulation rows from contaminated-platform rows. For this row, the levers below are ordered by impact magnitude based on the literature evidence base and per the Step 0 lock attribution of platform-level metal load. Brand-legal teams evaluating HMTc Cat 2 certification eligibility for this row should treat the formulation/sourcing levers as the dominant compliance pathway.

1. Maintain the clean-baseline formulation choice. The Row 7 clean baseline exists precisely because alternative ingredient classes (without the platform load) are commercially available. Brands certifying this row commit to NOT adopting the contaminated variant’s ingredient class.
2. Sourcing-level controls on the few remaining ingredient classes carrying trace metal load.
3. Testing/QC levers: lot-level ICP-MS on raw materials and finished product.

How standards math uses this page

The percentile arithmetic that informs HMTc Cat 2 thresholds for this row lives on the staff Standards Workbench (data/workbench/standards/diaper-cream-non-zno.md, to be generated). This public page reports literature evidence; the workbench applies the Cat 2 methodology (which includes the OPERATING.md Part 7 initiative 3.1 non-ingestion-exposure supplement at Cat 2 (Children Personal Care) non-ingestion exposure pathways) to produce candidate threshold values. The gap between literature evidence and HMTc thresholds is named honestly on the workbench, not hidden.

Historical recalls and enforcement

Cat 2 (children’s personal care) regulatory enforcement is fragmented: cosmetics fall under FDA FD&C Act adulteration provisions without binding finished-product heavy-metal action levels; sunscreens fall under FDA OTC drug monograph; toothpaste falls under FDA cosmetic + OTC drug regulation. State-level enforcement is more active: Washington State Toxic-Free Cosmetics Act 2025 sets heavy-metal limits for cosmetic products sold in Washington; New York Toxic Children’s Cosmetic Products Act sets limits for children’s makeup. California Prop 65 enforcement actions on cosmetics (lip balm, lipstick, eye products) have established practical compliance thresholds via settlement agreements. EU Cosmetic Regulation 1223/2009 Annex II/III addresses cosmetic-ingredient restrictions but not finished-product action levels. Per CLAUDE.md Part 12, individual brand recall actions are not enumerated here; the recalls are framed as regulatory events that establish the operative compliance landscape.

Sources

Auto-generated from source-page frontmatter. The “Used on this page for” column is populated by the orchestrator’s POPULATE-SOURCE-LEGEND action; pending entries appear as *[awaiting synthesis]*.

Page history

The five most recent substantive edits to this page. The full version history lives in git; when DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.